XML 38 R22.htm IDEA: XBRL DOCUMENT
v3.20.4

Employee Benefit Plans | 12 Months Ended
--- | ---
Jan. 02, 2021
Share-based Payment Arrangement [Abstract] |
Employee Benefit Plans | Employee Benefit Plans Deferred Compensation and Savings Plans. The Company has a defined contribution savings plan (the "401(k) Plan") for substantially all U.S.-based full-time employees of the Company, which includes a Roth 401(k) option. The Company's common stock is one of several investment alternatives available under the 401(k) Plan. The Company has a discretionary match for the 401(k) Plan. In order to mitigate the financial impact of COVID-19, the Company suspended 401(k) matching for the majority of fiscal year 2020. Matching contributions made by the Company to the 401(k) Plan totaled approximately $1.0 million, $3.2 million and $2.8 million for fiscal years 2020, 2019 and 2018, respectively. The Company also has the right to make additional matching contributions not to exceed 15% of employee compensation. The Company did not make any additional matching contributions during fiscal years 2020, 2019 and 2018. Under the Fossil Group, Inc. and Affiliates Deferred Compensation Plan (the "Deferred Plan") eligible participants may elect to defer up to 50% of their salary or up to 100% of any bonuses paid pursuant to the terms and conditions of the Deferred Plan. In addition, the Company may make employer contributions to participants under the Deferred Plan from time to time. The Company made no contributions to the Deferred Plan during fiscal years 2020, 2019 and 2018. In prior periods, the Company made payments pursuant to the Deferred Plan into a Rabbi Trust. The funds held in the Rabbi Trust are directed to certain investments available through life insurance products. The Company had assets of $6.3 million and $5.2 million related to the Company's invested balances recorded in intangible and other assets—net and liabilities of $4.4 million and $4.6 million related to the participants' invested balances recorded in accrued expenses—other, each on the Company's consolidated balance sheets at the end of fiscal years 2020 and 2019, respectively. Stock-Based Compensation Plans. The Company’s grants under its current stock-based compensation plans generally include: (i) stock options, restricted stock units, and performance restricted stock units for its international employees, (ii) restricted stock units for its nonemployee directors, and (iii) stock appreciation rights, performance stock appreciation rights, restricted stock, restricted stock units, and performance restricted stock units for its U.S.-based employees. As of January 2, 2021, the Company had approximately $7.3 million of total unrecognized compensation cost related to non-vested share-based compensation arrangements granted under the Company's stock-based compensation plans. This cost is expected to be recognized over a weighted-average period of 1.4 years. All time-based or performance-based stock appreciation rights and restricted stock units are settled in shares of the Company's common stock. Long-Term Incentive Plans. An aggregate of 3,000,000 shares of the Company's common stock were reserved for issuance pursuant to the Company's 2016 Long-Term Incentive Plan ("2016 LTIP"), adopted in March 2016. Pursuant to the First Amendment to the Company’s 2016 Long-Term Incentive Plan, which was approved by our stockholders on May 23, 2018, the number of shares of the Company’s common stock authorized for issuance under the Company’s 2016 Long-Term Incentive Plan, as amended (the “2016 Plan”), was increased from 3,000,000 to 10,288,468, such additional shares consisting of (i) 5,000,000 additional shares of common stock and (ii) up to 2,288,468 shares of common stock subject to awards under the Company’s 2008 Long-Term Incentive Plan (the “2008 Plan”) that were outstanding on March 31, 2018 and, on or after March 31, 2018, are forfeited, expire or are canceled. Under the 2016 Plan, designated employees of the Company, including officers, certain contractors, and outside directors of the Company, are eligible to receive (i) stock options, (ii) stock appreciation rights, (iii) restricted or non-restricted stock awards, (iv) restricted stock units, (v) performance awards, (vi) cash awards, or (vii) any combination of the foregoing. The 2016 Plan is administered by the Compensation Committee of the Company's Board of Directors (the "Compensation Committee"). Each award issued under the 2016 Plan terminates at the time designated by the Compensation Committee, not to exceed ten years. The current outstanding stock options, stock appreciation rights, performance stock appreciation rights, restricted stock, restricted stock units and performance restricted stock units issued under the 2016 Plan predominantly have original vesting periods of three years. Time-based or performance-based stock appreciation rights and restricted stock units are predominately settled in shares of the Company's common stock. On the date of the Company’s annual stockholders meeting, each nonemployee director automatically receives restricted stock units with a fair market value of approximately $130,000, which vest 100% on the earlier of one year from the date of grant or the date of the Company's next annual stockholders meeting, provided such director is providing services to the Company or a subsidiary of the Company on that date. Notwithstanding the foregoing, the Company’s Board of Directors elected to take a 25% reduction of such annual grant in 2020, 2019 and 2018. In addition, for the 2020 annual grant, the Company's common stock price used to calculate the value of the annual grant was $15.00 (on May 20, 2020, the date of the annual grant, the midpoint of the high and low sales prices of the Company's common stock was $2.86 per share). Therefore, each nonemployee director received a grant on May 20, 2020 of restricted stock units with a fair market value of approximately $18,600. Stock Options, Stock Appreciation Rights and Performance Stock Appreciation Rights. The fair value of stock options, stock appreciation rights and performance stock appreciation rights granted under the Company's stock-based compensation plans were estimated on the date of grant using the Black-Scholes option pricing model. The expected term of the stock options represents the estimated period of time until exercise and is based on historical experience of similar awards. Expected stock price volatility is based on the historical volatility of the Company’s common stock. The risk‑free interest rate is based on the implied yield available on U.S. Treasury securities with an equivalent remaining term. The Company did not issue stock options, stock appreciation rights and performance stock appreciation rights in fiscal years 2020, 2019 and 2018. The following table summarizes stock option, stock appreciation rights and performance stock appreciation rights activity:
Stock Options and Stock Appreciation Rights | Shares |  | Weighted-Average Exercise Price |  | Weighted-Average Remaining Contractual Term (Years) |  | Aggregate Intrinsic Value
| in thousands |  |  |  |  |  | in thousands
Outstanding at December 30, 2017 | 2,177 |  |  | $ | 50.01 |  |  | 5.3 |  | $ | — |
Granted | — |  |  | — |  |  |  |  |
Exercised | (21) |  |  | 14.46 |  |  |  |  | 37 |
Forfeited or expired | (226) |  |  | 59.58 |  |  |  |  |
Outstanding at December 29, 2018 | 1,930 |  |  | 49.25 |  |  | 1.3 |  | 37 |
Granted | — |  |  | — |  |  |  |  |
Exercised | (13) |  |  | 13.65 |  |  |  |  | 18 |
Forfeited or expired | (1,408) |  |  | 39.84 |  |  |  |  |
Outstanding at December 28, 2019 | 509 |  |  | 76.13 |  |  | 2.5 |  | — |
Granted | — |  |  | — |  |  |  |  |
Exercised | — |  |  | — |  |  |  |  | — |
Forfeited or expired | (126) |  |  | 79.44 |  |  |  |  |
Outstanding at January 2, 2021 | 383 |  |  | 75.05 |  |  | 1.9 |  | — |
Exercisable at January 2, 2021 | 383 |  |  | $ | 75.05 |  |  | 1.9 |  | $ | — |
The aggregate intrinsic value in the table above is before income taxes and is based on the exercise price for outstanding and exercisable options/rights at January 2, 2021 and based on the fair market value of the Company's common stock on the exercise date for options/rights that were exercised during the fiscal year. Stock Options, Stock Appreciation Rights and Performance Stock Appreciation Rights Outstanding and Exercisable. The following tables summarize information with respect to stock options, stock appreciation rights and performance stock appreciation rights outstanding and exercisable at January 2, 2021:
Stock Options Outstanding |  | Stock Options Exercisable
Range of Exercise Prices | Number of Shares |  | Weighted-Average Exercise Price |  | Weighted-Average Remaining Contractual Term (Years) |  | Number of Shares |  | Weighted- Average Exercise Price
| in thousands |  |  |  |  |  | in thousands |  |
$55.04 - $82.55 | 44 |  |  | 81.23 |  |  | 0.2 |  | 44 |  |  | 81.23 |
$95.91 - $131.46 | 62 |  |  | 128.11 |  |  | 1.1 |  | 62 |  |  | 128.11 |
Total | 106 |  |  | $ | 108.76 |  |  | 0.8 |  | 106 |  |  | $ | 108.76 |
Stock Appreciation Rights Outstanding |  | Stock Appreciation Rights Exercisable
Range of Exercise Prices | Number of Shares |  | Weighted-Average Exercise Price |  | Weighted-Average Remaining Contractual Term (Years) |  | Number of Shares |  | Weighted- Average Exercise Price
| in thousands |  |  |  |  |  | in thousands |  |
$29.49 - $47.99 | 166 |  |  | 41.77 |  |  | 2.9 |  | 166 |  |  | 41.77 |
$55.04 - $82.55 | 59 |  |  | 77.98 |  |  | 1.9 |  | 59 |  |  | 77.98 |
$95.91 - $113.04 | 52 |  |  | 109.71 |  |  | 0.8 |  | 52 |  |  | 109.71 |
Total | 277 |  |  | $ | 62.17 |  |  | 2.3 |  | 277 |  |  | $ | 62.17 |
Restricted Stock, Restricted Stock Units and Performance Restricted Stock Units. The following table summarizes restricted stock, restricted stock unit and performance restricted stock unit activity:
Restricted Stock, Restricted Stock Units and Performance Restricted Stock Units | Number of Shares |  | Weighted-Average Grant Date Fair Value Per Share
| in thousands |  |
Nonvested at December 30, 2017 | 2,981 |  |  | $ | 20.84 |
Granted | 1,456 |  |  | 14.35 |
Vested | (1,040) |  |  | 25.21 |
Forfeited | (386) |  |  | 19.87 |
Nonvested at December 29, 2018 | 3,011 |  |  | $ | 17.86 |
Granted | 1,008 |  |  | 13.01 |
Vested | (1,293) |  |  | 17.92 |
Forfeited | (397) |  |  | 21.49 |
Nonvested at December 28, 2019 | 2,329 |  |  | $ | 15.16 |
Granted | 1,124 |  |  | 3.76 |
Vested | (1,127) |  |  | 16.42 |
Forfeited | (590) |  |  | 12.42 |
Nonvested at January 2, 2021 | 1,736 |  |  | $ | 7.90 |
The total fair value of shares/units vested during fiscal years 2020, 2019 and 2018 was $4.8 million, $17.6 million and $16.6 million, respectively. Other Retirement Plans. The Company maintains a defined benefit plan for its employees located in Switzerland. The plan is funded through payments to an insurance company. The payments are determined by periodic actuarial calculations. During fiscal years 2020, 2019 and 2018, the Company recorded pension gains (expenses) of ($1.3) million, $0.7 million and $(0.6) million, respectively, related to this plan. The liability for the Company's defined benefit plan was $14.5 million and $17.0 million at the end of fiscal years 2020 and 2019, respectively. This liability is recorded in other long-term liabilities on the Company's consolidated balance sheets. Under French law, the Company is required to maintain a defined benefit plan for its employees located in France, which is referred to as a "retirement indemnity." The amount of the retirement indemnity is based on the employee's last salary and duration of employment with the Company. The employee's right to receive the retirement indemnity is subject to the employee remaining with the Company until retirement. During fiscal years 2020, 2019 and 2018, the Company recorded pension gains (expenses) of $0.2 million, $(0.4) million and $0.4 million, respectively, for its retirement indemnity obligations. The liability for the Company's retirement indemnity was $1.2 million at the end of both fiscal years 2020 and 2019. This liability is recorded in other long-term liabilities on the Company's consolidated balance sheets.

X
- Definition The entire disclosure for defined contribution plans and compensation-related costs for equity-based compensation. + References No definition available. + Details
Name: | fosl_DefinedContributionPlansAndSharebasedPaymentsDisclosureTextBlock
Namespace Prefix: | fosl_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration